Letter to Editor
BibTex RIS Cite
Year 2024, Volume: 14 Issue: 1, 61 - 62, 24.04.2024
https://doi.org/10.26650/experimed.1404013

Abstract

References

  • Roma-Rodrigues C, Rivas-Garaa L, Baptista PV, Fernandes AR. Gene therapy in cancer treatment: why go nano? Pharmaceutics 2020; 12(3): 233. google scholar
  • Rao K. CRISPR-Cas13 and its applications in human therapeutics. J High Sch Sci 2021; 5(4): 1-21. google scholar
  • Granados-Riveron JT, Aquino-Jarquin G. CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Res 2018; 78(15): 4107-13. google scholar
  • Gao J, Luo T, Lin N, Zhang S, Wang J. A new tool for CRISPR-Cas13a-based cancer gene therapy. Mol Ther Oncolytics 2020; 19: 79-92. google scholar

Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept

Year 2024, Volume: 14 Issue: 1, 61 - 62, 24.04.2024
https://doi.org/10.26650/experimed.1404013

Abstract

The promise of AI and CRISPR-Cas13a in cancer gene therapy is a harmony of development and hope. With the use of AI and CRISPR-Cas13a's molecular precision, as well as AI's computational power, cancer treatments may be administered with unprecedented precision and adaptability in the future.

References

  • Roma-Rodrigues C, Rivas-Garaa L, Baptista PV, Fernandes AR. Gene therapy in cancer treatment: why go nano? Pharmaceutics 2020; 12(3): 233. google scholar
  • Rao K. CRISPR-Cas13 and its applications in human therapeutics. J High Sch Sci 2021; 5(4): 1-21. google scholar
  • Granados-Riveron JT, Aquino-Jarquin G. CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Res 2018; 78(15): 4107-13. google scholar
  • Gao J, Luo T, Lin N, Zhang S, Wang J. A new tool for CRISPR-Cas13a-based cancer gene therapy. Mol Ther Oncolytics 2020; 19: 79-92. google scholar
There are 4 citations in total.

Details

Primary Language English
Subjects Clinical Sciences (Other)
Journal Section Letter to the Editor
Authors

Tungki Pratama Umar 0000-0001-6975-8096

Publication Date April 24, 2024
Submission Date December 12, 2023
Acceptance Date February 5, 2024
Published in Issue Year 2024 Volume: 14 Issue: 1

Cite

Vancouver Umar TP. Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept. Experimed. 2024;14(1):61-2.